Sanofi Wins Japan Approval for Wayrilz in Rare Blood Disease
PARIS, June 23, 2026 Sanofi has secured an important regulatory milestone after Japan’s Ministry of Health, Labour and Welfare...
Japan approval
Advertisement
Incyte Secures Japan Approval for Minjuvi in DLBCL Care
WILMINGTON, Del., June 20, 2026 Incyte Biosciences Japan G.K. has announced that Japan’s Ministry of Health, Labour and Welfare...
GSK Expands Arexvy Approval for At-Risk Adults
LONDON, United Kingdom, May 20, 2026 GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved...
Dupixent Approved in Japan for Rare Skin Disease
PARIS, FRANCE & TARRYTOWN, NEW YORK, USA | March 24, 2026 Sanofi and Regeneron have announced that Japan’s Ministry...
Pharming Group Secures Japan Approval for Joenja in APDS
LEIDEN, NETHERLANDS, March 24, 2026 Pharming Group has announced that Japan’s Ministry of Health, Labour and Welfare has approved...
Advertisement
